Pembrolizumab with chemoradiation, then with or without olaparib, for untreated unresectable locally advanced non-small-cell lung cancer [ID6399]

  • In development
  • GID-TA11499
  • Expected publication date: TBC

NIHRIO BN: 29961-Pembrolizumab-Olaparib-for-Non-Small-Cell-Lung-Cancer-V1.0-DEC2023-NON-CONF.pdf (nihr.ac.uk)